• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Topics » Expert Q&A

Expert Q&A
Expert Q&A RSS Feed RSS

EXPERT Q&A

Personal Privacy Versus Public Safety: Addiction Among Health Professionals

March 30, 2020
Paul H. Earley, MD, DFASAM
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information

Paul H. Earley, MD, DFASAM
Medical director of the Georgia Professionals Health Program, Inc. Distinguished Fellow of ASAM. President of the Federation of State Physician Health Programs. Dr. Earley has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Paul Earley, president-elect of the Federation of Physician Health Programs, outlines the offerings of physician health programs, how to engage yourself or colleagues in treatment, and how treatment may interface with medical boards.
Read More
EXPERT Q&A

Reduced Life Expectancy in ADHD

February 11, 2020
Russell Barkley, PhD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Russell Barkley, PhD
Clinical Professor of Psychiatry at The Virginia Commonwealth University Medical Center, Department of Psychiatry and the Virginia Treatment Center for Children Dr. Barkley has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Russell Barkley, PhD, discusses the enormity of the health consequences and early mortality associated with ADHD. The range and likely mechanism of long-term effects of ADHD are discussed, and we examine the role of assertive treatment in childhood and adolescence.
Read More
EXPERT Q&A

Reimagining ADHD

February 11, 2020
Edward Hallowell, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Edward Hallowell, MD
Child and adult psychiatrist. Founder of The Hallowell Centers in Boston MetroWest, New York City, San Francisco, and Seattle. Host of the podcast “Distraction” (www.distractionpodcast.com) Dr. Hallowell has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

While medication is the mainstay of treating symptoms in ADHD, Edward Hallowell, MD, shares a positive, relationship-based approach to ADHD with practical strategies to help children and adolescents manage ADHD.
Read More
EXPERT Q&A

The Clinician’s Role: Reducing Harm Among People Who Use Drugs

February 11, 2020
Kimberly Sue, MD, PhD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information

Kimberly Sue, MD, PhD
Medical Director of the Harm Reduction Coalition (www.harmreduction.org). Attending physician at Rikers Island Correctional Health Services, NY. Dr. Sue has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Addiction researcher and medical director of the Harm Reduction Coalition shares her approach to patients and provides state-specific resources for clinicians interested in connecting with harm reduction resources locally.
Read More
EXPERT Q&A

Inflammatory Biomarkers in Depression

February 10, 2020
Andrew H. Miller, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Andrew H. Miller, MD

William P. Timmie Professor of Psychiatry and Behavioral Sciences, Emory University, GA Dr. Miller has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Andrew Miller, Vice Chair of Psychiatry Research at Emory University, translates two decades research on inflammation and depression into practical terms, including a low-cost biomarker that may guide antidepressant selection.
Read More
EXPERT Q&A

Light and Darkness in Bipolar Disorder

February 1, 2019
Jim Phelps, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Jim Phelps, MDJim Phelps, MD
Psychiatrist and author, Corvallis, OR. Creator, psycheducation.org Dr. Phelps has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Jim Phelps is the author of a textbook on bipolar spectrum disorders, A Spectrum Approach to Mood Disorders: Not Fully Bipolar But Not Unipolar—Practical Management (W. W. Norton & Company) as well as two self-help books on bipolar disorder. He conducted some of the early studies on dark therapy out of his private practice in Oregon, and we caught up with him to learn about this novel treatment for bipolar disorder.
Read More
EXPERT Q&A

Effects of Drug Interactions

November 1, 2018
Neil Sandson, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Neil Sandson, MD. 
Clinical Associate Professor, Department of Psychiatry at University of Maryland School of Medicine

Dr. Sandson has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

When it comes to computer alerts for drug interactions, the two issues to pay attention to are toxicity and loss of efficacy. Toxicity is the bigger concern, particularly if the drug has a “narrow therapeutic index,” where modest differences in the level can have dangerous effects.
Read More
EXPERT Q&A

Neurobiology Concepts for Psychiatrists

June 1, 2018
David M. Kaufman, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
David M. Kaufman, MD Department of Neurology, Montefiore Medical Center, Bronx, NY. Co-author of Kaufman’s Clinical Neurology for Psychiatrists, 8th ed. (Elsevier). Dr. Kaufman has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
The most common cause of parkinsonism is Parkinson disease, but parkinsonism also can occur from the use of any medication that blocks the D2 (dopamine type 2) receptor. Those include antipsychotics but can also include non-psychiatric medicines, particularly metoclopramide (Reglan), an anti-nausea medicine.
Read More
EXPERT Q&A

Acting Out: Is It Anxiety?

March 1, 2018
Ira Glovinsky, PhD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Ira Glovinsky, PhD.  Licensed psychologist and principal at the Glovinsky Center for the Child and the Family in West Bloomfield, MI. Dr. Glovinsky has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We are all busy clinicians, but if we pause and take note of our natural responses and learn how we typically respond to various kinds of kids, we gain a valuable tool that supports our ability to effectively and efficiently assess a child.
Read More
EXPERT Q&A

How to Evaluate and Treat Mood Disorders in Pregnancy

July 1, 2016
Vivien Burt, PhD, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Vivien Burt, PhD, MD

Founder and co-director at UCLA Women’s Life Center, a perinatal outpatient program in Los Angeles, CA.

Dr. Burt discloses that she has been a paid consultant to Otsuka, Sunovion, Lundbeck, and Takeda. Dr. Puzantian has reviewed this article and has found no evidence of bias in this educational activity.

Dr. Vivien Burt discusses mood disorders and pregnancy. It’s now pretty widely recognized that pregnancy does not protect against mental illness, and the postpartum period is certainly a time of very high vulnerability for women, especially if they’ve had a history of psychiatric illness.
Read More
Previous 1 2 … 7 8 9 10 11 12 13 14 15 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2635946985.jpg
    General Psychiatry

    AI in Practice

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.